Revelation Partners

Revelation Partners, LLC is a private equity firm specializing in buyout, direct and fund of fund investments. It prefers to invest in late stage companies. The firm seeks to provide capital and liquidity to investors, companies, and funds. It also specializes in making secondary investments. The firm typically invests in healthcare sector with a focus on medical devices, biopharmaceuticals, healthcare information technology, and healthcare services. It typically invest between $5 million and $30 million with the ability to do larger deals in conjunction with the limited partners. The firm may also purchase the ownership of an existing investor who desires liquidity. It also provides follow on investments. The firm prefers to take majority stake in companies. Revelation Partners, LLC is based in San Francisco, California.

Mike Boggs

Managing Partner

FL

Fred Lee

MD

Zack Scott

Managing Partner

ZR

Zachary R. Scott

Managing Partner

SS

Suchira Sharma

Associate

21 past transactions

Dren Bio

Series B in 2022
Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.

SetPoint Medical

Venture Round in 2021
SetPoint Medical Corporation, a clinical-stage bioelectronic medicine company, develops implantable neuromodulation devices for treating patients with debilitating inflammatory diseases. SetPoint Medical Corporation was formerly known as Innovative Metabolics Inc. and changed its name to SetPoint Medical Corporation in July 2008. The company was incorporated in 2006 and is based in Valencia, California.

Vertos Medical

Venture Round in 2017
Vertos Medical is a healthcare company that offers medical devices used in the treatment of common spinal diseases. The company commercializes the percutaneous treatment for lumbar spinal stenosis (LSS). It also offers minimally invasive lumbar decompression devices for the treatment of various forms of LSS. The company offers its devices in the United States. Vertos Medical, Inc. was founded by Dr. Dave Solsberg and Dr. Don Schomer in 2005 and is headquartered in Aliso Viejo, California, USA.

Gravie, Inc.

Series E in 2022
Gravie is a health insurance marketplace designed to help consumers choose and buy insurance, pay for it, and manage all health care expenses in one place. Gravie specializes in the fields of health insurance, health care, and employer benefits. It was founded in 2013 and headquartered in Minneapolis, Minnesota.

Providence Medical Technology

Venture Round in 2018
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance.

Endeavor BioMedicines

Series B in 2022
Endeavor BioMedicines is developing new treatments targeting the underlying causes of pulmonary fibrosis.

Genome Medical

Series B in 2020
Genome Medical, Inc. operates a platform that provides genetic consultation and medical consulting services to individuals. The company through its Genome Care Delivery technology platform provides genetic solutions in the areas of clinical care, such as cancer, cardio, proactive, reproductive, pediatric, and pharmacy. Genome Medical, Inc. was incorporated in 2016 and is based in South San Francisco, California.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience, Inc. develops induced pluripotent stem cells to treat neurological conditions. Its products pipeline includes ANPD001, an autologous neuron replacement therapy in sporadic Parkinson disease; and ANPD002, a gene-edited autologous neuron replacement therapy for familial forms of Parkinson disease. The company was incorporated in 2018 and is based in San Diego, California.

IntelyCare

Series C in 2022
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

SPR Therapeutics, LLC

Series D in 2021
SPRA Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. They are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach. The first product to be commercialized is the SMARTPATCHâ„¢ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain.

HotSpot Therapeutics

Series C in 2021
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. The company's platform helps to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery enabling patients to get treatment against several diseases.

ClearCorrect, LLC

Private Equity Round in 2016
ClearCorrect is the clear and simple choice. No wires. No brackets. Just clear, convenient comfort—every reason to smile. With ClearCorrect, your dentist or orthodontist can straighten your teeth using a series of clear, custom, removable aligners. Each aligner moves your teeth just a little bit at a time until you eventually get straight teeth.

Genome Medical

Series C in 2021
Genome Medical, Inc. operates a platform that provides genetic consultation and medical consulting services to individuals. The company through its Genome Care Delivery technology platform provides genetic solutions in the areas of clinical care, such as cancer, cardio, proactive, reproductive, pediatric, and pharmacy. Genome Medical, Inc. was incorporated in 2016 and is based in South San Francisco, California.

Click Therapeutics

Series B in 2021
Click Therapeutics, Inc. engineers, validates, develops, and commercializes digital therapeutics solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. It develops and commercializes novel digital therapeutics for various indications, including smoking cessation, major depressive disorders, schizophrenia, insomnia, acute coronary syndrome, migraine, overactive bladder, chronic low back pain, and obesity. Click Therapeutics, Inc. was founded in 2012 and is based in New York, New York.

Gravie, Inc.

Series D in 2021
Gravie is a health insurance marketplace designed to help consumers choose and buy insurance, pay for it, and manage all health care expenses in one place. Gravie specializes in the fields of health insurance, health care, and employer benefits. It was founded in 2013 and headquartered in Minneapolis, Minnesota.
Nuvolo Technologies Corporation provides a cloud-based enterprise asset management platform under the name ServiceNow. The company provides life-cycle management solutions for enterprise assets of clinics, laboratories, facilities, and manufacturers. Additionally, it offers implementation, support, tracking, reporting, and analytics solutions. The company has strategic partnerships with Atos, Fruition Partners, InSource, KPMG, and Unisys. Nuvolo Technologies Corporation was founded in 2013 and is based in Paramus, New Jersey with additional offices in London, United Kingdom; Sofia, Bulgaria; and Pune, India.

Evidation Health

Series D in 2020
Evidation Health is a provider of a health data analytics platform designed to collect and analyze continuous behavior data and healthcare information so as to create better health outcomes. Its platform turns raw, high-frequency everyday behavior data from sensors, devices, speech, video, and other sources into new knowledge about health and disease, that enable individuals and innovative companies to understand and influence the everyday behaviors. It was founded in 2012 and is headquartered in San Mateo, California.

NeuroPace

Private Equity Round in 2020
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.

Arterys Inc.

Series C in 2020
Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions.

SomaLogic

Series A in 2020
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

Syapse

Series F in 2020
Syapse works with leading health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients. By bringing these organizations together into the Syapse Learning Health Network, Syapse has built one of the world’s largest networks dedicated to improving outcomes in cancer care through improved precision medicine. Syapse and its partners are working towards a future in which all cancer patients have access to the quality of care they need. The company was founded in 2008 and is headquartered in San Francisco, California.